Janus Henderson Biotech Innovation Master Fund Ltd insider trades: ARCA biopharma (ABIO) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Janus Henderson Biotech Innovation Master Fund Ltd reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 16, 2024 | ABIO | ↑ Buy | 5,818 | $2.93 | $17K | By Fund | Aug 20, 2024 (4d) |
| Jul 25, 2024 | ABIO | ↑ Buy | 220,083 | $3.18 | $699K | By Fund | Jul 26, 2024 (1d) |
| Jul 11, 2024 | ABIO | ↑ Buy | 408,777 | $3.49 | $1.4M | By Fund | Jul 12, 2024 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Janus Henderson Biotech Innovation Master Fund Ltd's insider trades
Janus Henderson Biotech Innovation Master Fund Ltd is a 10% owner of ARCA biopharma (ABIO). Since Jul 11, 2024, it has reported 3 open-market purchases worth $2.1M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ABIO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.